Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brendan John Murphy is active.

Publication


Featured researches published by Brendan John Murphy.


Journal of Pharmaceutical Sciences | 2017

Mechanism and Kinetics of Punch Sticking of Pharmaceuticals

Shubhajit Paul; Lisa J. Taylor; Brendan John Murphy; Joseph F. Krzyzaniak; Neil Dawson; Matthew P. Mullarney; Paul Meenan; Changquan Calvin Sun

Adherence of powder onto tablet tooling, known as punch sticking, is one of the tablet manufacturing problems that need to be resolved. An important step toward the resolution of this problem is to quantify sticking propensity of different active pharmaceutical ingredients (APIs) and understand physicochemical factors that influence sticking propensity. In this study, mass of adhered material onto a removable upper punch tip as a function of number of compression is used to monitor sticking kinetics of 24 chemically diverse compounds. We have identified a mathematical model suitable for describing punch sticking kinetics of a wide range of compounds. Chemical analyses have revealed significant enrichment of API content in the adhered mass. Based on this large set of data, we have successfully developed a new punch sticking model based on a consideration of the interplay of interaction strength among API, excipient, and punch surface. The model correctly describes the general shape of sticking profile, that is, initial rise in accumulated mass followed by gradual increase to a plateau. It also explains why sometimes sticking is arrested after monolayer coverage of punch surface by API (punch filming), while in other cases, API buildup is observed beyond monolayer coverage.


International Journal of Pharmaceutics | 2017

Powder properties and compaction parameters that influence punch sticking propensity of pharmaceuticals

Shubhajit Paul; Lisa J. Taylor; Brendan John Murphy; Joseph F. Krzyzaniak; Neil Dawson; Matthew P. Mullarney; Paul Meenan; Changquan Calvin Sun

Punch sticking is a frequently occurring problem that challenges successful tablet manufacturing. A mechanistic understanding of the punch sticking phenomenon facilitates the design of effective strategies to solve punch sticking problems of a drug. The first step in this effort is to identify process parameters and particle properties that can profoundly affect sticking performance. This work was aimed at elucidating the key material properties and compaction parameters that influence punch sticking by statistically analyzing punch sticking data of 24 chemically diverse compounds obtained using a set of tooling with removable upper punch tip. Partial least square (PLS) analysis of the data revealed that particle surface area and tablet tensile strength are the most significant factors attributed to punch sticking. Die-wall pressure, ejection force, and take-off force also correlate with sticking, but to a lesser extent.


Pharmaceutical Development and Technology | 2005

Use of the antioxidant BHT in asymmetric membrane tablet coatings to stabilize the core to the acid catalyzed peroxide oxidation of a thioether drug.

Michael J Puz; Barbara Alice Johnson; Brendan John Murphy

The application of a controlled-release asymmetric membrane (AM) coating containing cellulose acetate and polyethylene glycol 3350 (PEG3350) to a stable osmotic tablet core resulted in the oxidative degradation of active ingredient located in the core. It was hypothesized that the production of hydroperoxides from PEG3350 in the coating was responsible for the electrophilic oxidation of drug to the sulfoxide degradation product. The type and solubility of carboxylic acid excipient used to formulate the drug release profile of the osmotic tablet significantly influenced the amount of oxidation. By adding the antioxidant butylated hydroxytoluene (BHT) to the coating, oxidation was significantly inhibited in tablets placed on accelerated stability. Of three additives that were used to prevent oxidation [BHT, ferrous sulfate, and ethylenediaminetetraacetic acid (EDTA)], BHT was shown to be the most effective at preventing sulfoxide formation. The BHT was also shown to be more effective in the coating rather than in the core due to its location closer to the source of the oxidizing species, PEG3350, in the coating.


Bioorganic & Medicinal Chemistry Letters | 2013

Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.

Benjamin D. Stevens; John Litchfield; Jeffrey A. Pfefferkorn; Karen Atkinson; Christian Perreault; Paul Amor; Kevin B. Bahnck; Martin A. Berliner; Jessica Calloway; Anthony A. Carlo; David R. Derksen; Kevin J. Filipski; Mike Gumkowski; Charanjeet Jassal; Margit MacDougall; Brendan John Murphy; Paul Nkansah; John C. Pettersen; Charles J. Rotter; Yan Zhang

Glucokinase (hexokinase IV) continues to be a compelling target for the treatment of type 2 diabetes given the wealth of supporting human genetics data and numerous reports of robust clinical glucose lowering in patients treated with small molecule allosteric activators. Recent work has demonstrated the ability of hepatoselective activators to deliver glucose lowering efficacy with minimal risk of hypoglycemia. While orally administered agents require a considerable degree of passive permeability to promote suitable exposures, there is no such restriction on intravenously delivered drugs. Therefore, minimization of membrane diffusion in the context of an intravenously agent should ensure optimal hepatic targeting and therapeutic index. This work details the identification a hepatoselective GKA exhibiting the aforementioned properties.


Journal of Pharmaceutical Sciences | 2012

Thermodynamic stability considerations for isostructural dehydrates.

Brendan John Murphy; Melissa J. Casteel; Brian Samas; Joseph F. Krzyzaniak

Nonstoichiometric channel hydrates are a class of crystalline hydrates that can incorporate a range of water levels as a function of temperature and relative humidity (RH). When a nonstoichiometric channel hydrate can dehydrate to yield a physically stable isostructural crystalline lattice, it may become challenging to accurately evaluate the thermodynamic stability relationship associated with a polymorphic system using traditional methods. This work demonstrates application of a eutectic-melting method to determine the stability relationship between a nonstoichiometric channel dehydrate and an anhydrous form. A transition temperature (122°C) between the isostructural dehydrate of the nonstoichiometric channel hydrate and the anhydrous polymorph was identified, with the nonstoichiometric channel hydrate being the thermodynamically stable anhydrous form at room temperature (RT). Solid-state storage at a range of RH conditions demonstrated that the nonstoichiometric channel hydrate is also the stable form at RT above an RH of 94%. These results demonstrate that the nonstoichiometric channel hydrate is the stable form at low temperatures, independent of its hydration state. It has been demonstrated that the eutectic-melting method is applicable to the study of thermodynamic stability relationships between anhydrous forms and dehydrated channel hydrates.


Journal of Pharmaceutical Sciences | 2017

Dependence of Punch Sticking on Compaction Pressure—Roles of Particle Deformability and Tablet Tensile Strength

Shubhajit Paul; Kunlin Wang; Lisa J. Taylor; Brendan John Murphy; Joseph F. Krzyzaniak; Neil Dawson; Matthew P. Mullarney; Paul Meenan; Changquan Calvin Sun

Punch sticking is a complex phenomenon influenced primarily by particle size, tooling surface roughness, tooling design, and tooling construction material. When particle and environmental factors are controlled, compaction pressure has a distinct effect on punch sticking behavior for a given active pharmaceutical ingredient (API). This research focuses on the effect of compaction pressure on punch sticking using 5 compounds with different sticking propensities. The results collectively show that sticking tends to be more problematic under higher compaction pressures and for more ductile compounds. This is attributed to the greater punch surface coverage by the API and the stronger cohesion of API to the existing API layer on the punch.


Journal of Pharmaceutical Sciences | 2010

Varenicline L-tartrate Crystal Forms: Characterization Through Crystallography, Spectroscopy, and Thermodynamics

Brendan John Murphy; Jun Huang; Melissa J. Casteel; Ana Cobani; Joseph F. Krzyzaniak

This research utilized crystallographic, spectroscopic, and thermal analysis data to assess the thermodynamic stability relationship between the three known crystal forms of Varenicline L-tartrate. Of the two anhydrous forms (Forms A and B), Form B was determined to be the stable form at 0 K based on its calculated true density, hydrogen bonding in the crystal lattice, and application of the IR rule. Form A has a higher melting point and higher solubility at room temperature as compared to Form B, indicating that these forms are enantiotropically related. Application of the eutectic-melting method enabled accurate determination of the transition temperature (63 degrees C), with Form B as the stable anhydrous form at room temperature. The stability relationships between the anhydrous polymorphs and the monohydrate (Form C) were assessed through exposure of the anhydrous forms to a range of water vapor pressures at room temperature. A phase boundary was identified, with the monohydrate being the thermodynamically stable form above critical water activity values of 0.85 and 0.94 for Forms A and B, respectively. These results provide a better understanding of the form stability as it relates to normal manufacturing and storage conditions for the active pharmaceutical ingredient and drug product.


Archive | 2005

Directly compressible formulations of azithromycin

Brendan John Murphy; Steven William Collier; Ernest Shing Quan; Barbara Alice Johnson


Archive | 2003

Stable non-dihydrate azithromycin oral suspensions

Steven William Collier; William John Curatolo; Barbara Alice Johnson; Brendan John Murphy


Archive | 2012

Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer

Brendan John Murphy; Timothy D. White; Brian P. Chekal; Phillip J. Johnson; Christopher James Foti; Leonid A. Margulis

Researchain Logo
Decentralizing Knowledge